Widespread gene transfection into the central nervous system of primates

Gene Therapy

Volumn 7, Issue 9, 2000, Pages 759-763

  Hagihara, Y ^a   Saitoh, Y ^a   Kaneda, Y ^a   Kohmura, E ^a   Yoshimine, T ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Central nervous system; Gene therapy; HVJ liposome; Primates

Indexed keywords

LIPOSOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CENTRAL NERVOUS SYSTEM; CEREBELLUM VERMIS; CERVICAL SPINAL CORD; CISTERNA MAGNA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; LIPID COMPOSITION; MACACA; NERVE CELL; NONHUMAN; PRIMATE; PRIORITY JOURNAL; PURKINJE CELL; TEMPORAL LOBE; TRANSGENE; VIRUS ENVELOPE;

ANIMALIA; MACACA; PRIMATES;

EID: 0034102551     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301169     Document Type: Article

References (16)

1. Leiden JM. Gene therapy - promise, pitfalls, and prognosis. New Engl J Med 1995; 13: 871-873.
2. Wang C, Chao C, Maddedu P. Central delivery of human tissue kallikrein gene reduces blood pressure in hypertensive rats. Biochem Biophys Res Commun 1998; 244: 449-454.
3. Mandel RJ, Spratt SK, Snyder RO. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rat. Proc Natl Acad Sci USA 1997; 94: 14083-14088.
4. Linnik MD, Zahos P, Geschwind MD. Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke 1995; 26: 1670-1675.
5. Lawrence MS, Ho DY, Sun GH. Overexpression of bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J Neurosci 1996; 15: 486-496.
6. Lawrence MS, McLaughlin JR, Sun G-H. Herpes simplex viral vectors expressing bcl-2 are neuroprotective when delivered after a stroke. J Cereb Blood Flow Metab 1997; 7: 740-744.
7. Blömer U, Naldini L, Kafri T. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol 1997; 71: 6641-6649.
8. Naldini L, Blömer U, Gage FH. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 1996; 93: 11382-11388.
9. Yamada Y, Moriguchi A, Morishita R. Efficient oligonucleotide delivery using the HVJ-liposome method in the central nervous system. Am J Physiol 1996; 271: R1212-R1220.
10. Kaneda Y et al. The improved efficient method for introducing macromolecules into cells using HVJ (Sendai virus). Exp Cell Res 1987; 173: 56-69.
11. Hirano T et al. Persistent gene expression in rat liver in vivo by repetitive transfections using HVJ-liposome. Gene Therapy 1998; 5: 459-464.
12. Crystal RG. Transfer of genes to humans: early lessons and obstacles to success. Science 1995; 270: 404-410.
13. Saeki Y et al. Developement and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer. Hum Gene Ther 1997; 8: 2133-2141.
14. Hagihara Y, Saitoh Y, Kaneda Y. Brain protection by the transfection of bcl-2 gene into the entire central nervous system (CNS). Rest Neurol Neurosci 1998; 13: 221-235.
15. Mabuchi E et al. Gene delivery by HVJ-liposome in the experimental gene therapy of murine glioma. Gene Therapy 1997; 4: 768-772.
16. Baskar JF et al. The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type specific expression in transgenic mice. J Virol 1996; 70: 3207-3214.